Our News on Newswise

Newswise: 61a668adbb573_4019aed3-bdb6-444b-b0e9-9d20bcfed3c1.png

FDA Approves “Glowing Tumor” Imaging Drug to Better Identify Ovarian Cancer Cells Using Approach Pioneered by Surgeons at the University of Pennsylvania

FDA approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
30-Nov-2021 1:40 PM EST Add to Favorites

About 12 Percent of Patients Who Receive Common Cardiac Device Implants Develop Persistent Opioid Use

About 12 percent of patients who receive implantable cardiac devices such as a pacemaker or defibrillator and fill an opioid prescription after surgery will consistently use the pain medication in the months afterward, raising the potential for...
26-Nov-2021 4:05 PM EST Add to Favorites

$10 Million Gift Establishes New Colton Center for Autoimmunity at Penn Medicine

The Perelman School of Medicine at the University of Pennsylvania will continue to be on the leading edge of autoimmune research and care with the launch of the Colton Center for Autoimmunity at Penn. The new center unites research and patient care...
18-Nov-2021 9:00 AM EST Add to Favorites

Common Gene Variants Linked to Sepsis and COVID-19 Severity in African Americans

Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania’s Perelman School of Medicine have found.
16-Nov-2021 5:05 PM EST Add to Favorites

Automated Texting System Saved Lives Weekly During First COVID Surge

Patients enrolled in COVID Watch, an algorithmically driven text messaging system backed by a small team of nurses, were 68 percent less likely to die from COVID-19
3-Nov-2021 12:10 PM EDT Add to Favorites

Moderate Amounts of Caffeine Not Linked to Maternal Health Risks

Consuming a low amount of caffeine during pregnancy could help to reduce gestational diabetes risk, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.
11-Nov-2021 4:35 PM EST Add to Favorites

Newswise: 618ad162166e7_GettyImages-1299730658.jpg

Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits

Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School of...
9-Nov-2021 3:30 PM EST Add to Favorites

Newswise: 618573e5e8ea4_Polite headshot.jpg

Penn’s Florencia Greer Polite, MD, Named to 2022 Carol Emmott Fellowship Class

Florencia Greer Polite, MD, chief of the Division of General Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, has been selected for the 2022 Carol Emmott Fellowship class by the Carol Emmott Foundation,...
5-Nov-2021 2:35 PM EDT Add to Favorites


See All News

Our YouTube Videos

About

The Department of Communications is responsible for managing the communications function of the Perelman School of Medicine and the University of Pennsylvania Health System. We do so by promoting and protecting the reputation of the institution and its physicians and staff as well as creating awareness of the educational, research, and patient care activities of Penn Medicine.

Our Media Relations and Publications divisions are committed to serve all of the communications needs of Penn Medicine — which includes the Hospital of the University of Pennsylvania (HUP), Penn Presbyterian Medical Center (PPMC), Chester County Hospital (CCH), Lancaster General Health (LGH), Penn Medicine Princeton Health (PMPH), and Pennsylvania Hospital (PAH), the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

We are dedicated to quickly respond to your information needs and encourage you to call our office if you have questions about the Health System or School of Medicine.

Experts

Contacts

Holly Auer
Associate Vice President for Communications
cancer

holly.auer@uphs.upenn.edu

215-349-5659

Caren Begun
Senior Cancer Communications Officer

Caren.Begun@Pennmedicine.upenn.edu

267-408-9196

Alex Gardner
Press Officer

alex.gardner@pennmedicine.upenn.edu

2153498062

Steve Graff
Communications Consultant

Stephen.Graff@Pennmedicine.upenn.edu

Lauren Ingeno
Press Officer

lauren.ingeno@pennmedicine.upenn.edu

215-327-2203

Sophie Kluthe
Senior Medical Communications Officer

sophie.kluthe@pennmedicine.upenn.edu

(267) 588-5939

Brandon Lausch
Senior News Director

brandon.lausch@pennmedicine.upenn.edu

Hannah Messinger
Assistant Director, Strategic Communications

hannah.messinger@pennmedicine.upenn.edu

215-349-5653

Melissa Moody
Senior Science Communications Officer

moodymel@pennmedicine.upenn.edu

215-407-3536

Kelsey Odorczyk
Press Officer

kelsey.odorczyk@pennmedicine.upenn.edu

215-300-1194

Frank Otto
Senior Medical Information Officer

Frank.Otto@pennmedicine.upenn.edu

2676932999

Ylonda Russell
Administrative Assistant

russelyl@uphs.upenn.edu

215-349-5658

Twitter

close
1.03088